Min Liang
- Cancer Research top 2%
- Cancer-related molecular mechanisms research 16
- MicroRNA in disease regulation 13
- Molecular Biology top 10%
- Circular RNAs in diseases 9
- RNA Interference and Gene Delivery 4
- RNA modifications and cancer 4
- Biochemistry top 10%
-
- Cancer Mechanisms and Therapy 5
-
- Autophagy in Disease and Therapy 5
-
- Nanoplatforms for cancer theranostics 4
- Journals
- SHILAP Revista de lepidopterología (1 paper)Molecular Cell (1 paper)PLoS ONE (1 paper)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Min Liang
79 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 125
- Cancer Research 734
- Molecular Biology 1.2k
- Immunology 178
- Oncology 191
- Biochemistry 48
Countries citing papers authored by Min Liang
This map shows the geographic impact of Min Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Liang more than expected).
Fields of papers citing papers by Min Liang
This network shows the impact of papers produced by Min Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Liang. The network helps show where Min Liang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Min Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 5 | |
| 4 | 2024 | 1 | |
| 5 | 2023 | 17 | |
| 6 | 2023 | 9 | |
| 7 | 2023 | 3 | |
| 8 | 2023 | 51 | |
| 9 | 2023 | 19 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 22 | |
| 13 | 2022 | 3 | |
| 14 | 2021 | 4 | |
| 15 | 2021 | 22 | |
| 16 | 2020 | 12 | |
| 17 | Babaodan inhibits cell growth by inducing autophagy through the PI3K/AKT/mTOR pathway and enhances antitumor effects of cisplatin in NSCLC cells. | 2019 | 17 |
| 18 | 2016 | 1 | |
| 19 | [LY294002 blocks the effect of dexamethasone in reducing urine protein in rats by inhibiting PI3K/Akt signaling pathway]. | 2016 | 0 |
| 20 | 2016 | 15 |
About Min Liang
Min Liang is a scholar working on Cancer Research, Microbiology and Developmental Neuroscience, having authored 88 papers that have together received 1.9k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (16 papers), MicroRNA in disease regulation (13 papers), Circular RNAs in diseases (9 papers), Cancer Mechanisms and Therapy (5 papers), Autophagy in Disease and Therapy (5 papers), RNA Interference and Gene Delivery (4 papers), Nanoplatforms for cancer theranostics (4 papers) and RNA modifications and cancer (4 papers). The work is most often cited by research in Cancer Research (734 citations), Molecular Biology (1.2k citations) and Immunology (178 citations). Min Liang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Xinke Zhou, Guanqun Huang, Xianhan Jiang, Ye Lin, Chong Wang, Jianhong Huang, Peiqing Li, Yidan Zhang, Haiyan Liu and Wenxia Yao. Their work appears in journals such as SHILAP Revista de lepidopterología, Molecular Cell and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.